Upregulation of epidermal growth factor and its receptor in the kidneys of rats with streptozotocin-induced diabetes
- PMID: 9001888
Upregulation of epidermal growth factor and its receptor in the kidneys of rats with streptozotocin-induced diabetes
Abstract
We have studied the acute changes (up to 30 days) in the expression of epidermal growth factor (EGF) and its receptor (EGFr) in the kidneys of adult male Wistar rats made diabetic by a single intravenous injection of streptozotocin (55 mg/kg) using a combination of immunocytochemical staining and in situ hybridization histochemistry. In the absence of insulin treatment, diabetic rats displayed renal growth (hypertrophy and hyperplasia). It was accompanied by an increase in immunostainable EGF within the thick ascending limb (TAL) of the loops of Henle which was apparent within 24 h of the onset of diabetes, reached a peak by day 7 and persisted to the end of the experimental period (day 30). In situ hybridization histochemistry revealed that these changes were preceded by a rapid rise in EGF mRNA in the cells of the TAL, which was highest after 1 day but declined to control levels by day 7. Increased immunostainable EGFr was evident in both the proximal and TAL and in the cortical collecting ducts from day 1. Staining of the proximal tubules declined rapidly after day 1 but that of the TAL and collecting ducts persisted until day 7 and declined thereafter. These results are discussed in light of the role of EGF in the hypertrophy and repair of the diabetic kidney.
Similar articles
-
Increased epidermal growth factor in experimental diabetes related kidney growth in rats.Diabetologia. 1997 Jul;40(7):778-85. doi: 10.1007/s001250050749. Diabetologia. 1997. PMID: 9243098
-
Insulin-like growth factor-I and experimental diabetic kidney disease.Exp Nephrol. 1993 Nov-Dec;1(6):364-71. Exp Nephrol. 1993. PMID: 8081988
-
Hyperplasia, hypertrophy, and phenotypic alterations in the distal nephron after acute proximal tubular injury in the rat.Lab Invest. 1994 Apr;70(4):479-93. Lab Invest. 1994. PMID: 7909858
-
Molecular targeting of the epidermal growth factor receptor for neutron capture therapy of gliomas.Cancer Res. 2002 Jun 1;62(11):3159-66. Cancer Res. 2002. PMID: 12036929
-
Spatiotemporal distribution of insulin-like growth factor receptors during nephrogenesis in fetuses from normal and diabetic rats.Cell Tissue Res. 2003 Dec;314(3):367-79. doi: 10.1007/s00441-003-0803-4. Epub 2003 Oct 2. Cell Tissue Res. 2003. PMID: 14523643
Cited by
-
Epidermal growth factor receptor tyrosine kinase-mediated signalling contributes to diabetes-induced vascular dysfunction in the mesenteric bed.Br J Pharmacol. 2005 Jul;145(6):829-36. doi: 10.1038/sj.bjp.0706238. Br J Pharmacol. 2005. PMID: 15852031 Free PMC article.
-
Expression-based network biology identifies alteration in key regulatory pathways of type 2 diabetes and associated risk/complications.PLoS One. 2009 Dec 7;4(12):e8100. doi: 10.1371/journal.pone.0008100. PLoS One. 2009. PMID: 19997558 Free PMC article.
-
Epidermal growth factor promotes transforming growth factor-β1-induced epithelial-mesenchymal transition in HK-2 cells through a synergistic effect on Snail.Mol Biol Rep. 2014 Jan;41(1):241-50. doi: 10.1007/s11033-013-2857-z. Epub 2013 Nov 8. Mol Biol Rep. 2014. PMID: 24203464
-
Diabetic cardiomyopathy: Role of epidermal growth factor receptor tyrosine kinase.J Mol Cell Cardiol. 2015 Jul;84:10-2. doi: 10.1016/j.yjmcc.2015.04.002. Epub 2015 Apr 10. J Mol Cell Cardiol. 2015. PMID: 25865396 Free PMC article. No abstract available.
-
Interaction of the EGF Receptor and the Hippo Pathway in the Diabetic Kidney.J Am Soc Nephrol. 2016 Jun;27(6):1689-700. doi: 10.1681/ASN.2015040415. Epub 2015 Oct 9. J Am Soc Nephrol. 2016. PMID: 26453611 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Research Materials
Miscellaneous